CN114981191B - 用于管理食物过敏口服免疫疗法药物的分发和治疗的方法和系统 - Google Patents

用于管理食物过敏口服免疫疗法药物的分发和治疗的方法和系统

Info

Publication number
CN114981191B
CN114981191B CN202080080794.0A CN202080080794A CN114981191B CN 114981191 B CN114981191 B CN 114981191B CN 202080080794 A CN202080080794 A CN 202080080794A CN 114981191 B CN114981191 B CN 114981191B
Authority
CN
China
Prior art keywords
patient
registration
healthcare
information
management database
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202080080794.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN114981191A (zh
Inventor
A·达纳
D·阿德尔曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA filed Critical Societe des Produits Nestle SA
Publication of CN114981191A publication Critical patent/CN114981191A/zh
Application granted granted Critical
Publication of CN114981191B publication Critical patent/CN114981191B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Databases & Information Systems (AREA)
  • Nutrition Science (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN202080080794.0A 2019-11-20 2020-11-19 用于管理食物过敏口服免疫疗法药物的分发和治疗的方法和系统 Active CN114981191B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962938180P 2019-11-20 2019-11-20
US62/938,180 2019-11-20
US202063056492P 2020-07-24 2020-07-24
US63/056,492 2020-07-24
PCT/US2020/061362 WO2021102186A1 (en) 2019-11-20 2020-11-19 Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug

Publications (2)

Publication Number Publication Date
CN114981191A CN114981191A (zh) 2022-08-30
CN114981191B true CN114981191B (zh) 2025-08-15

Family

ID=75909665

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080080794.0A Active CN114981191B (zh) 2019-11-20 2020-11-19 用于管理食物过敏口服免疫疗法药物的分发和治疗的方法和系统

Country Status (8)

Country Link
US (2) US20220415464A1 (cg-RX-API-DMAC7.html)
EP (1) EP4061753A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023502423A (cg-RX-API-DMAC7.html)
CN (1) CN114981191B (cg-RX-API-DMAC7.html)
AU (1) AU2020388398A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022009664A2 (cg-RX-API-DMAC7.html)
CA (1) CA3162233A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021102186A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7756664B2 (ja) 2020-07-01 2025-10-20 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 経口免疫療法のための医療スタッフ配置の決定
US12100510B2 (en) 2022-10-10 2024-09-24 CareMetx, LLC System and method for enrollment into patient service programs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2616511A1 (en) * 2007-07-06 2009-01-06 Catalyst Healthcare Ltd. Medication dose administration and inventory management
CN104039171A (zh) * 2012-01-19 2014-09-10 雀巢产品技术援助有限公司 包含特定瑞士乳杆菌菌株并且降低食物过敏和/或呼吸道变态反应症状的组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797515A (en) * 1995-10-18 1998-08-25 Adds, Inc. Method for controlling a drug dispensing system
US20090019552A1 (en) * 2000-03-15 2009-01-15 Mclaughlin Mark R Healthcare Medical Information Management System
US7668730B2 (en) * 2002-12-17 2010-02-23 JPI Commercial, LLC. Sensitive drug distribution system and method
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
US8386274B1 (en) * 2008-09-17 2013-02-26 Mckesson Financial Holdings Limited Systems and methods for a prescription safety network utilizing eligibility verification transactions
WO2010104841A2 (en) * 2009-03-09 2010-09-16 Celgene Corporation Device for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated and methods for use thereof
US8392219B1 (en) * 2010-05-10 2013-03-05 Mckesson Financial Holdings Limited Systems and methods for streamlined patient enrollment for one or more healthcare programs
US10189616B2 (en) * 2010-08-13 2019-01-29 Daniel L. Kraft System and methods for the production of personalized drug products
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
US20130292294A1 (en) * 2012-05-03 2013-11-07 Brandon J. Wilson Allergy emergency kit
MX2015010315A (es) * 2013-03-14 2016-04-13 Aimmune Therapeutics Inc Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en) * 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
CA2907915C (en) * 2013-04-03 2023-03-07 Allertein Therapeutics, Llc Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components
TWI755763B (zh) * 2013-06-04 2022-02-21 美商再生元醫藥公司 藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
US20170021010A1 (en) * 2015-07-21 2017-01-26 David Phillip ERSTEIN Allergy preventing dosage controlled food packets
CA3003869A1 (en) * 2015-11-04 2017-05-11 Bayer Healthcare Llc Barcode database and software update system
EP3440579A4 (en) * 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
US12702642B2 (en) * 2017-12-06 2026-08-11 Atg Acquisition Llc Composition and method for reducing allergic response

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2616511A1 (en) * 2007-07-06 2009-01-06 Catalyst Healthcare Ltd. Medication dose administration and inventory management
CN104039171A (zh) * 2012-01-19 2014-09-10 雀巢产品技术援助有限公司 包含特定瑞士乳杆菌菌株并且降低食物过敏和/或呼吸道变态反应症状的组合物

Also Published As

Publication number Publication date
CA3162233A1 (en) 2021-05-27
US20210151155A1 (en) 2021-05-20
EP4061753A4 (en) 2023-12-13
EP4061753A1 (en) 2022-09-28
JP2023502423A (ja) 2023-01-24
AU2020388398A1 (en) 2022-04-21
WO2021102186A1 (en) 2021-05-27
BR112022009664A2 (pt) 2022-08-16
CN114981191A (zh) 2022-08-30
US20220415464A1 (en) 2022-12-29

Similar Documents

Publication Publication Date Title
Hayden et al. The challenges of COVID-19 for community pharmacists and opportunities for the future
US20250029701A1 (en) Methods of regulating access to qsymia to mitigate potential drug-associated risks
Cubanski et al. What happens when COVID-19 emergency declarations end? Implications for coverage, costs, and access
Sullivan et al. Medication reconciliation in the acute care setting: opportunity and challenge for nursing
US20080201173A1 (en) Methods for delivering a drug to a patient while restricting access to the drug by patients for whom the drug may be contraindicated
Anagnostou Weighing the benefits and risks of oral immunotherapy in clinical practice
Anagnostou et al. The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology
TW200419422A (en) Method and system for integrating data flows
Adams et al. Pharmacists' Patient Care Process: a state “Scope of practice” perspective
US20100256984A1 (en) Method and system to control and enhance prescribing and dispensing of medication
US20210295971A1 (en) Sensitive drug distribution systems and methods
CN114981191A (zh) 用于管理食物过敏口服免疫疗法药物的分发和治疗的方法和系统
US7885824B1 (en) Method and system for delivering medical therapies
US11830615B2 (en) Device-based risk management of a therapeutic
Throneberry et al. Optimizing long-acting injectable antipsychotic safety and care continuity through documentation best practices
US20020156653A1 (en) System and method for prescribing unregulated therapeutic substances in an integrated medical health care program
Omotosho et al. Electronic prescription system for pediatricians
Schriefer et al. Medication reconciliation in the outpatient primary care setting: Barriers and opportunities
Pincus Transitional care management services: optimizing medication reconciliation to improve the care of older adults
Duncan et al. Individualized virtual integrative medicine (IVIM): A clinical model for enhanced GLP-1 therapeutic outcomes
Babbar et al. Irrational use of drugs–a review
Deslandes et al. Medicines management
Marimuthu Should direct to consumer advertisements (DTCA) of prescription drugs remain banned in Malaysia?
JP2002351985A (ja) リアルタイム・薬剤オーダーチェックシステム
Zaro et al. Clinicians Approach Chronic Pain/Opioid Therapy Differently

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant